Ann: Management Update, page-11

First 11 Last

Share
Profile

Follow
Nige456

4,567 Posts.

348

14/09/18

13:04

Post #: 35603648
Share

Originally posted by lordolean ↑

I think you are writing it off all too soon....the core business seems to be going just fine, indeed better than fine....however there has obviously been a "botch up" by the CEO around the treatment of the new chargeoff accounting..which was poorly communicated to the market and caused a massive selloff in the stock....but the reality of it was that there wasnt too much drama in the credit numbers when adjusted for accounting changes....and credit costs remain below peers.

So what we have is a mismanagement of the information release......and clearly the major shareholder family has moved against the CEO too push him out, using this as an excuse....I agree all not good but so long as the core business is fine then I think we still have a viable business. Hence my question about any fraud that may have happened........multiple people have recently audited the company and found nothing so.....I would be hopefully on that score.

So what I would expect to see;

Business strategy change to slow growth a bit, probably pull out of Canada etc which was brainchild of the CEO.
Search for new CEO and CFO.
Appointment of outsider to restore confidence of the market in the book (audit).
possible small equity raising backed by founding family as underwriters.
Keep an eye out for things outside of the norm.......

just some thoughts. I wouldnt write it off just yet..

Expand

it will collapse. it is looking terrible. i am wondering what the so called 'auditors' are doing really? pfft.

AXL Price at posting: $1.63 Sentiment: None Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

COB

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

OJC

SPC to merge with Original Juice Co and Nature One Dairy

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 18 more messages in this thread...

First 11 Last

Add AXL (ASX) to my watchlist

(20min delay)
Last 9.3¢		Change 0.000(0.00%)		Mkt cap ! $6.920M

Open	High	Low	Value	Volume
9.3¢	9.3¢	9.3¢	$4.144K	44.56K

Buyers (Bids)

No.	Vol.	Price($)
1	33333	9.0¢

Sellers (Offers)

Price($)	Vol.	No.
9.3¢	31830	1

View Market Depth

No.	Vol.	Price($)
1	33333	0.090
3	105487	0.088
1	25000	0.087
1	25798	0.086
2	107529	0.085

Price($)	Vol.	No.
0.093	31830	1
0.094	19986	1
0.095	100000	1
0.096	80000	1
0.099	100000	1

Last trade - 14.23pm 02/10/2024 (20 minute delay)

AXL (ASX) Chart

Ann: Management Update, page-11

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

SPC to merge with Original Juice Co and Nature One Dairy

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Management Update, page-11

Top Stories

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

SPC to merge with Original Juice Co and Nature One Dairy

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News